Popular Press

Call us Now

+41 44 741 8181

Call Back

Request Here

Make Appointment

Come to us @ ELZA

Email Us

info@elza-institute.com

Recommend Us

Thank you!

Telemedicine

Online consultation

The pathophysiology and pathomorphology of corneal ectasia
  • Farhad Hafezi, Popular press
The pathophysiology and pathomorphology of corneal ectasia
This month’s issue of Ophthalmology Times Europe saw the publication of a review article, “The pathophysiology and pathomorphology of corneal ectasia” authored by Prof. Hafezi, Medical Director of the ELZA Institute, and Dr. Omid Kermani, Managing Director at Augenklinik am Neumarkt in Cologne.
  • by Mark Hillen
  • November 17, 2022
Read More
News: CXL reimbursed in Switzerland
  • Farhad Hafezi, Popular press
Crosslinking insurance reimbursement in Switzerland
Newsflash: CXL reimbursed in Switzerland Exactly 20 years after the clinical introduction of cross-linking and after more than 2,000 scientific publications on the subject, corneal cross-linking (CXL) for the treatment of progressive keratoconus has now been included in the Swiss healthcare reimbursement system (the “krankenkasse”).
  • by Mark Hillen
  • July 4, 2022
Read More
A photograph of an article of Farhad Hafezi in the Limmattaler Zeiting
  • Farhad Hafezi, Popular press, Top 10
Farhad Hafezi profiled in the Limmattaler Zeitung
Prof. Farhad Hafezi was recently profiled in the Swiss newspaper, Limmattaler Zeitung, in which he discussed everything from his pioneering research into corneal cross-linking (CXL), how he has spent the last two decades improving CXL to better treat not just keratoconus, but infections of the cornea too – in a way that doesn’t require antibiotics or antifungal drugs to kill the infectious organisms.
  • by Prof. Farhad Hafezi
  • October 8, 2021
Read More
PREV34567Next
.
.